Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Nephrologic/Hepatologic Conditions
Vol. 1, Issue 3, 2014
December 18, 2013 EDT
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
Jona T. Stahmeyer
,
Svenja Schauer
,
Siegbert Rossol
,
Hans Heinrich Wedemeyer
,
Daniel Wirth
,
Florence Bianic
,
Christian Krauth
,
germany
markov model
triple-therapy
cost-effectiveness analysis
hepatitis c
Copyright Logo
ccby-4.0
JHEOR
1.
Stahmeyer JT, Schauer S, Rossol S, et al. Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany.
JHEOR
. 2013;1(3):239-253.
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats